
Exsegen Genomics Research Private Limited
About Exsegen Genomics Research Private Limited
Data last updated:
Exsegen Genomics Research Private Limited is a private limited company based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the scientific research segment of the research and development sector. It was incorporated on 05 February 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73100TG2020PTC139009.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹33.35 Lakh. It is led by directors including Amitava Ray (Managing Director) and Surya Prakash Madiraju.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Third Floor 8 – 2 – 293/82/A/240 Road No. 36 Jubilee Hills, Hyderabad, Telangana, India – 500033.
As per the financials filed for FY 2024, the company reported a revenue of ₹73,472, a decline of 25% compared to the previous year. For the same year it recorded a net loss of ₹23.95 Lakh and EBITDA of -₹21.87 Lakh.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Exsegen Genomics Research
Contact details
Exsegen Genomics Research Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressThird Floor 8 – 2 – 293/82/A/240 Road No. 36 Jubilee Hills, Hyderabad, Telangana, India – 500033
- IndustryResearch & Development, Science Research
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Exsegen Genomics Research Private Limited
FY 2025 filings availableExsegen Genomics Research Private Limited reported revenue of ₹73,472 (down 25% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 25% in the latest year. EBITDA fell 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹21.87 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹23.95 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Exsegen Genomics Research Private Limited, buy the company report.
Board of directors of Exsegen Genomics Research Private Limited
Exsegen Genomics Research has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Goutam Bhattacharyya | Additional Director | 19 Oct 2022 | 4 Years 1 Months | Current |
| Amitava Ray Also directs: Exsegen Research Foundation, Gbmdx LLP | Managing Director | 05 Feb 2020 | 6 Years 9 Months | Current |
| Surya Prakash Madiraju Also directs: Legalcraft Technologies Private Limited, Legalcraft Solutions Private Limited, Annomap Technologies Private Limited and 3 more | Director | 05 Feb 2020 | 6 Years 9 Months | Current |
Peer comparison
Exsegen Genomics Research Private Limited is compared with the 10 companies closest to it by revenue in the Biotechnology industry (Biotechnology, Genomics), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Raspa Pharma Private Limited | ₹78,208 (FY 2024) | 354.0% | Lucknow, Uttar Pradesh, India | |||
| Perfect Healthcare and Biotechnology Private Limited | ₹76,354 (FY 2019) | -98.0% | Mumbai, Maharashtra, India | |||
| Icon Scientific Systems Private Limited | ₹75,533 (FY 2025) | -73.0% | Thane, Maharashtra, India | |||
| Snpcode Private Limited | ₹75,000 (FY 2024) | Bangalore, Karnataka, India | ||||
| Nuerepa Biotechnology Private Limited | ₹73,835 (FY 2021) | New Delhi, Delhi, India | ||||
| Exsegen Genomics Research Private Limitedthis company | ₹73,472 (FY 2024) | -₹23.95 Lakh | -25.0% | Hyderabad, Telangana, India | ||
| Mauli Bioplants and Research Private Limited | ₹68,667 (FY 2025) | -9.0% | Pune, Maharashtra, India | |||
| Aepss Biotech Private Limited | ₹64,370 (FY 2025) | 2.0% | Jagadhri, Haryana, India | |||
| Pentoreum Innovations Private Limited | ₹61,980 (FY 2021) | 20.0% | Kottayam, Kerala, India | |||
| Simbiosys Biowares India Private Limited | ₹59,180 (FY 2016) | Bangalore, Karnataka, India | ||||
| Mablon Biotech Private Limited | ₹58,945 (FY 2019) | 244.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Exsegen Genomics Research Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Exsegen Genomics Research Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Exsegen Genomics Research Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Exsegen Genomics Research Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Exsegen Genomics Research Private Limited has 5 board changes on record since 2020: 4 appointments and 1 cessation. The latest: Goutam Bhattacharyya was appointed as Additional Director on 19 Oct 2022.
Frequently asked questions
Exsegen Genomics Research is an active private limited company based in Hyderabad, Telangana, India. The company works in science research, within the research and development industry. It was incorporated on 05 February 2020 (6+ years old) and is registered under CIN U73100TG2020PTC139009.
Exsegen Genomics Research has 3 current directors:
- Amitava Ray - Managing Director
- Goutam Bhattacharyya - Additional Director
- Surya Prakash Madiraju - Director
The latest financial statements of Exsegen Genomics Research on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Exsegen Genomics Research is U73100TG2020PTC139009. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Exsegen Genomics Research was incorporated on 05 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Exsegen Genomics Research by revenue are Raspa Pharma Private Limited, Perfect Healthcare and Biotechnology Private Limited, Icon Scientific Systems Private Limited, Snpcode Private Limited, Nuerepa Biotechnology Private Limited and 5 more, all in the Biotechnology industry (Biotechnology, Genomics).
Goutam Bhattacharyya was appointed as Additional Director on 19 Oct 2022. Abhinav Rao Thangeda ceased to be Director on 17 Sep 2020. Abhinav Rao Thangeda was appointed as Director on 05 Feb 2020. Exsegen Genomics Research has 5 board changes on record in total.
Yes, Exsegen Genomics Research is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Exsegen Genomics Research is at Third Floor 8 – 2 – 29382A240 Road No. 36 Jubilee Hills, Hyderabad, Telangana, India – 500033.
Exsegen Genomics Research operates in the research and development industry, in the science research segment.
The compliance status of Exsegen Genomics Research is compliant as of 20 July 2026. The company is actively filing with the Registrar of Companies.

